Category Archives: Press Release

2018 audit

...

Portage Biotech Inc. (CSE: PBT.U, OTC Markets: PTGEF) (“Portage” or the “Company”) is pleased to announce that it has been granted an extension by the Canadian Securities Exchange (the “CSE”) to remedy its default under CSE listing rules.

...

Portage Announces Change of CEO

Toronto, Ontario, May 6, 2019 – The Board of Directors of Portage Biotech Inc. (“Portage” or...

Portage makes additional investment in Stimunity S.A. a Paris-Based Cancer immunotherapy company

Toronto, Ontario, March 25, 2019 – Portage Biotech Inc. (“Portage” or “the Company”) (Canadian...

Portage Announces Change of Auditors

Toronto, Ontario, March 12, 2019 (PBT.U: CSE, PTGEF: OTC Markets) – Portage Biotech Inc. (“Portage”...

CSE to Issue Final Bulletin Regarding SalvaRx Acquisition

PORTAGE BIOTECH INC. NEWS RELEASE CSE to Issue Final Bulletin Regarding SalvaRx Acquisition  ...

Portage provides updates on trading of its shares on OTC Markets

...

Shareholders approve Acquisition of SalvaRx Limited

...

Portage Provides Additional Information on SalvaRx acquisition

...

Further subscription of US$950,000 in Convertible Loan to iOx

...